Back to Search
MURRAY JOINER, MD
MD
Physical Medicine & Rehabilitation Physician
NPI: 1477595973IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
0101046633(VA)
Education
MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.
PMID 19362251·Int J Radiat Oncol Biol Phys·2009
8-other
Radiation-induced adaptive response is not seen in cell lines showing a bystander effect but is seen in lines showing HRS/IRR response.
PMID 19205987·Int J Radiat Biol·2009
8-other
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.
PMID 18455987·Cell·2008
7-preclinical
Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia.
PMID 18073348·Blood·2008
7-preclinical
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
PMID 17846228·Blood·2007
8-other
Effective palliation without normal tissue toxicity using low-dose ultrafractionated re-irradiation for tumor recurrence after radical or adjuvant radiotherapy.
PMID 17851878·Acta Oncol·2007
3-trial
The MTCP1 oncogene modifies T-cell homeostasis before leukemogenesis in transgenic mice.
PMID 17136114·Leukemia·2007
7-preclinical
Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity.
PMID 17967316·Int J Radiat Oncol Biol Phys·2007
7-preclinical
MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy?
PMID 17873139·J Nucl Med·2007
6-review
Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks.
PMID 16669705·Radiat Res·2006
7-preclinical
Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.
PMID 16861697·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
PMID 16307003·Gene Ther·2006
7-preclinical
Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
PMID 16808622·Radiat Res·2006
7-preclinical
Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
PMID 15818381·Cancer Gene Ther·2005
8-other
Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo.
PMID 16449082·Int J Radiat Biol·2005
7-preclinical
Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma.
PMID 16044223·Strahlenther Onkol·2005
4-observational
VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions.
PMID 15729368·Gene Ther·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2726 ELECTRIC ROAD
ROANOKE, VA 24018 - Phone
- (540) 772-4448
Quick Facts
- NPI
- 1477595973
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile